(Q33932031)

30 July 2017

1 reference

title

Melanoma. A multidisciplinary approach for the general surgeon (English)

1 reference

30 July 2017

Reeves ME

1

1 reference

30 July 2017

Coit DG

series ordinal

2

1 reference

30 July 2017

publication date

1 April 2000

1 reference

Surgical Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

80

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

581-601

1 reference

Adjuvant interferon treatment for melanoma

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Adjuvant therapy of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): prognostic factors analysis and preliminary results of immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II)

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Sentinel lymph node evaluation in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Hematogenous spread of malignant melanoma cells in different stages of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Roentgenographic visualization of human testicular lymphatics: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

An approach for the treatment of penile carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Margin of resection in the management of primary melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Results of adjuvant interferon study in WHO melanoma programme

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Prognosis of skin melanoma with regional node metastases (stage II)

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Immunophenotyping of melanomas for tyrosinase: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Recent cancer trends in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Strategy of the EORTC-MCG trial programme for adjuvant treatment of moderate-risk and high-risk melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Role of elective lymph node dissection in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Lymphatic mapping and sentinel lymphadenectomy for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Minimal-access surgery for staging of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Optimal selective sentinel lymph node dissection in primary malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Intraoperative identification of sentinel lymph node in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

T Cell Recognition of Haptens, a Molecular View

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Increased effectiveness of interferon alfa-2b following active specific immunotherapy for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of neuroblastoma cells in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Overview of melanoma vaccines: active specific immunotherapy for melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Interferons and their actions

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Recent advances in the chemistry of melanogenesis in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of micrometastases in patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

The orderly progression of melanoma nodal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Lymphatic mapping and selective lymphadenectomy as an alternative to elective lymph node dissection in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Role of lymphatic mapping and sentinel node biopsy in the detection of melanoma nodal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Molecular staging of malignant melanoma: correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Inefficacy of immediate node dissection in stage 1 melanoma of the limbs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Cytodiagnosis of malignant melanoma. Immunoperoxidase staining with HMB-45 antibody as an aid to diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Vaccines and other adjuvant therapies for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Lymphatic drainage of skin to a sentinel lymph node in a feline model.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970202-4

7 January 2021

10.1016/S0039-6109(05)70202-4

Identifiers

DOI

1 reference

30 July 2017

1 reference